Page last updated: 2024-08-18

phenformin and Bile Duct Cancer

phenformin has been researched along with Bile Duct Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jaidee, R; Kongpetch, S; Kukongviriyapan, U; Kukongviriyapan, V; Prawan, A; Senggunprai, L1
Cheng, Q; Feng, F; Gan, W; Hu, S; Jiang, X; Ouyang, Q; Qiao, L; Shi, Y; Wang, J; Wu, D1

Other Studies

2 other study(ies) available for phenformin and Bile Duct Cancer

ArticleYear
Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
    Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:9

    Topics: AMP-Activated Protein Kinases; Angiogenesis Inhibitors; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Culture Media, Conditioned; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasm Invasiveness; Neovascularization, Physiologic; Oxidative Stress; Phenformin; Phosphorylation; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A

2020
Phenformin inhibits cell proliferation and induces cell apoptosis and autophagy in cholangiocarcinoma.
    Molecular medicine reports, 2018, Volume: 17, Issue:4

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Disease Models, Animal; Humans; Male; Mice; Phenformin; Protein Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2018